Changes in related circular RNAs following ERβ knockdown and the relationship to rBMSC osteogenesis-Reference-Cited by-同舟云学术

Changes in related circular RNAs following ERβ knockdown and the relationship to rBMSC osteogenesis

Published:2017-11 Issue:1 Volume:493 Page:100-107
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Li Xiaoyun^ORCID,Peng Bojia,Zhu Xiaofeng,Wang Panpan,Xiong Yingquan,Liu Hengrui,Sun Kehuan,Wang Haixia,Ou Ling,Wu Zhidi,Liu Xiaoguang,He Haibin,Mo Shu,Peng Xunqian,Tian Ya,Zhang Ronghua,Yang Li

Funder

National Natural Science Foundation of China

national natural fund youth science fund

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. Tissue-specific effects of loss of estrogen during menopause and aging;Wend;Front. Endocrinol.,2012

2. Cloning of a novel receptor expressed in rat prostate and ovary;Kuiper;Proc. Natl. Acad. Sci. U. S. A.,1996

3. Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse;Xu;Environ. Sci. Pollut. Res.,2017

4. Estrogen receptor beta signals to inhibition of cardiac fibrosis;Pedram;Mol. Cell. Endocrinol.,2016

5. Effects of estrogen receptor beta stimulation in a rat model of non-bacterial prostatic inflammation;Mizoguchi;Prostate,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technetium-99m-methylene diphosphonate single photon emission computed tomography/computed tomography combined with prostate-specific antigen/free prostate-specific antigen ratio for bone metastasis of prostate cancer;World Journal of Clinical Cases;2024-07-16

2. LINC01354 affect glioma survival;2024-07-02

3. The p53-mediated cell cycle regulation is a potential mechanism for emodin-suppressing osteosarcoma cells;Heliyon;2024-03

4. Dexmedetomidine Affects Triple-Negative Breast Cancer by Targeting IDO1 and CHRM3;J BIOL REG HOMEOS AG;2024

5. Dexmedetomidine impacts IDO1 and CHRM3 in breast cancer;2024-02-07